Palisade Bio (PALI) announced the appointment of Laurent Peyrin-Biroulet, MD, PhD and David Rubin, MD, two internationally recognized leaders in inflammatory bowel disease, to its Clinical Advisory Board.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PALI: